J Costa-Rodrigues1, A Fernandes, M H Fernandes. 1. Laboratório de Farmacologia e Biocompatibilidade Celular, Faculdade de Medicina Dentária, Universidade do Porto, Porto, Portugal.
Abstract
OBJECTIVES: Osteoclasts are descended from the CD14(+) monocyte/macrophage lineage, but influence of other haematopoietic cells on osteoclastic commitment of their precursors has remained poorly understood. In this study, osteoclastogenic behaviour of peripheral blood mononuclear cells (PBMC) and their CD14(+) and CD14(-) subpopulations has been accessed, in the absence or presence of M-CSF and RANKL. MATERIALS AND METHODS: Cell cultures were characterized for presence of actin rings and vitronectin and calcitonin receptors, TRAP activity and calcium phosphate resorbing activity, expression of osteoclast-related genes and secretion of M-CSF and RANKL. RESULTS: In the absence of growth factors, PBMC and CD14(+) cultures had some degree of cell survival, and some spontaneous osteoclastogenesis was observed, only on cultures of the former. Supplementation with M-CSF and RANKL significantly increased osteoclastogenic behaviour of cell cultures, particularly CD14(+) cell cultures. Nevertheless, PBMC derived a higher degree of osteoclastogenesis, either as absolute values or after normalization by protein content. It was observed that unlike CD14(+) cells, PBMC were able to express M-CSF and RANKL, which increased following growth factor treatment. Also, expression of TNF-α, GM-CSF, IL-1β, IL-6 and IL-17 was higher in PBMC cultures. Finally, CD14(-) cultures exhibited limited cell survival and did not reveal any osteoclast features. CONCLUSIONS: Results show that although osteoclastic precursors reside in the CD14(+) cell subpopulation, other populations (such as CD14(-) cells) derived from PBMC, have the ability to modulate osteoclastogenesis positively.
OBJECTIVES: Osteoclasts are descended from the CD14(+) monocyte/macrophage lineage, but influence of other haematopoietic cells on osteoclastic commitment of their precursors has remained poorly understood. In this study, osteoclastogenic behaviour of peripheral blood mononuclear cells (PBMC) and their CD14(+) and CD14(-) subpopulations has been accessed, in the absence or presence of M-CSF and RANKL. MATERIALS AND METHODS: Cell cultures were characterized for presence of actin rings and vitronectin and calcitonin receptors, TRAP activity and calcium phosphate resorbing activity, expression of osteoclast-related genes and secretion of M-CSF and RANKL. RESULTS: In the absence of growth factors, PBMC and CD14(+) cultures had some degree of cell survival, and some spontaneous osteoclastogenesis was observed, only on cultures of the former. Supplementation with M-CSF and RANKL significantly increased osteoclastogenic behaviour of cell cultures, particularly CD14(+) cell cultures. Nevertheless, PBMC derived a higher degree of osteoclastogenesis, either as absolute values or after normalization by protein content. It was observed that unlike CD14(+) cells, PBMC were able to express M-CSF and RANKL, which increased following growth factor treatment. Also, expression of TNF-α, GM-CSF, IL-1β, IL-6 and IL-17 was higher in PBMC cultures. Finally, CD14(-) cultures exhibited limited cell survival and did not reveal any osteoclast features. CONCLUSIONS: Results show that although osteoclastic precursors reside in the CD14(+) cell subpopulation, other populations (such as CD14(-) cells) derived from PBMC, have the ability to modulate osteoclastogenesis positively.
Authors: N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda Journal: Proc Natl Acad Sci U S A Date: 1990-09 Impact factor: 11.205
Authors: B Fernandez Pujol; F C Lucibello; U M Gehling; K Lindemann; N Weidner; M L Zuzarte; J Adamkiewicz; H P Elsässer; R Müller; K Havemann Journal: Differentiation Date: 2000-05 Impact factor: 3.880
Authors: J Faust; D L Lacey; P Hunt; T L Burgess; S Scully; G Van; A Eli; Y Qian; V Shalhoub Journal: J Cell Biochem Date: 1999-01-01 Impact factor: 4.429
Authors: Victor Martin; Mónica Garcia; Maria de Fátima Montemor; João Carlos Salvador Fernandes; Pedro Sousa Gomes; Maria Helena Fernandes Journal: Bioengineering (Basel) Date: 2022-06-15
Authors: Inês P Perpétuo; Joana Caetano-Lopes; Elsa Vieira-Sousa; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca Journal: Front Med (Lausanne) Date: 2017-01-27
Authors: Inês Pedro Perpétuo; Joana Caetano-Lopes; Ana Maria Rodrigues; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João Eurico Fonseca Journal: RMD Open Date: 2017-07-13
Authors: Inês P Perpétuo; Joana Caetano-Lopes; Ana Maria Rodrigues; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca Journal: Biomed Res Int Date: 2017-02-13 Impact factor: 3.411
Authors: Elina Kylmäoja; Miho Nakamura; Hanna Kokkonen-Puuperä; Veli-Pekka Ronkainen; Petri Lehenkari; Juha Tuukkanen Journal: Heliyon Date: 2018-05-07